Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that Health Canada has issued a Notice of Compliance (NOC) authorizing REDEMPLO™ (plozasiran), a small interfering RNA (siRNA) medicine, ...
Here's what to know about 2026 Postal Service changes in postmark process, postage stamps and USPS shipping rates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback